KALI SCHEXNAYDER: Open Payments
NPI 1710632526 · SAINT AMANT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 19 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $196 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Novo Nordisk Inc | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $20 |
| Exact Sciences Corporation | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: QULIPTA, UBRELVY, BREZTRI, VRAYLAR, Kerendia, Quviviq, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across LA — which companies pay providers there.
